Hands M E, Antico V, Thompson P L, Hung J, Robinson J S, Lloyd B L
Department of Cardiovascular Medicine, Sir Charles Gairdner Hospital, Queen Elizabeth II Medical Centre, Nedlands, Western Australia.
Int J Cardiol. 1987 Nov;17(2):155-67. doi: 10.1016/0167-5273(87)90127-6.
The reasons for the poorer prognosis of anterior versus inferior myocardial infarction of equivalent enzymatic size remain uncertain. We investigated whether there are differences in left ventricular function between patients with anterior and inferior infarctions of equivalent enzymatic size to account for their differing outcomes. Clinical, serum enzyme, and electrocardiographic data were prospectively recorded in a consecutive series of patients less than 70 years of age with their first myocardial infarction. At 29 +/- 6 days following infarction, ejection fraction and left ventricular wall motion were assessed by gated heart scintigraphy and functional capacity by treadmill exercise testing in 19 patients with anterior and in 23 patients with inferior myocardial infarction. Peak creatine kinase and QRS scores were used to estimate total infarct size and left ventricular infarct size respectively. The anterior infarcts were of similar size to the inferior infarcts as determined by peak creatine kinase (1444 [mean] +/- 1161 [SD] U/L versus 1484 [mean] +/- 1182 [SD] U/L, respectively, P = 0.91) and peak aspartate transaminases (174 +/- 112 U/L versus 164 +/- 102 U/L, P = 0.78). The anterior myocardial infarct group had a greater percentage of the left ventricle infarcted on QRS scoring than the inferior infarct group (25.9 +/- 14.4% versus 11.1 +/- 6.0% respectively, P = 0.0004), lower global left ventricular ejection fraction (45.8 +/- 16% versus 54.6 +/- 9.2%, P = 0.04) and greater left ventricular regional wall abnormality. A significant negative correlation existed between left ventricular ejection fraction and peak creatine kinase for both groups, but was more marked with anterior infarction (r = -0.78, P less than 0.01) compared with inferior infarction (r = -0.49, P less than 0.05). Exercise-induced ST segment elevation was more frequent in the anterior than the inferior infarct group (59% versus 18%, P less than 0.02). However, both infarct locations had similar exercise tolerance, exercise-induced angina and ST segment depression. Despite equivalence of infarct size of the two infarct locations on enzyme testing, anterior infarction was associated with greater abnormality of left ventricular function with lower resting global left ventricular ejection fraction; greater resting left ventricular regional wall abnormality and greater exercise-induced ST segment elevation. These differences probably contribute to the poorer prognosis of patients with anterior infarction compared to those with inferior infarction of equivalent enzymatic size, given the previously well-documented prognostic importance of left ventricular function.
同等酶学指标大小的前壁心肌梗死较下壁心肌梗死预后更差的原因仍不明确。我们研究了同等酶学指标大小的前壁和下壁梗死患者左心室功能是否存在差异,以解释其不同的预后结果。前瞻性记录了一系列年龄小于70岁的首次心肌梗死患者的临床、血清酶和心电图数据。在心肌梗死后29±6天,通过门控心脏闪烁显像评估19例前壁心肌梗死患者和23例下壁心肌梗死患者的射血分数和左心室壁运动,并通过平板运动试验评估其功能能力。分别用肌酸激酶峰值和QRS评分来估计总梗死面积和左心室梗死面积。根据肌酸激酶峰值(分别为1444[均值]±1161[标准差]U/L和1484[均值]±1182[标准差]U/L,P = 0.91)和天冬氨酸转氨酶峰值(174±112 U/L和164±102 U/L,P = 0.78)确定,前壁梗死面积与下壁梗死面积相似。前壁心肌梗死组在QRS评分中左心室梗死的百分比高于下壁梗死组(分别为25.9±14.4%和11.1±6.0%,P = 0.0004),整体左心室射血分数较低(45.8±16%和54.6±9.2%,P = 0.04),左心室局部壁异常更明显。两组的左心室射血分数与肌酸激酶峰值之间均存在显著负相关,但前壁梗死组更为显著(r = -0.78,P<0.01),而下壁梗死组为(r = -0.49,P<0.05)。前壁梗死组运动诱发的ST段抬高比下壁梗死组更频繁(59%对18%,P<0.02)。然而,两个梗死部位的运动耐量、运动诱发的心绞痛和ST段压低相似。尽管酶学检测显示两个梗死部位的梗死面积相当,但前壁梗死与左心室功能更大异常相关,静息时整体左心室射血分数更低;静息时左心室局部壁异常更明显,运动诱发的ST段抬高更显著。鉴于先前充分证明的左心室功能对预后的重要性,这些差异可能导致同等酶学指标大小的前壁梗死患者比下壁梗死患者预后更差。